HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne L Peters Selected Research

Diabetic Ketoacidosis (Ketoacidosis, Diabetic)

12/2021The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
11/2021The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
1/2021Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 Inhibitor.
11/2020Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies.
6/2020The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth.
11/2019Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.
6/2019International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
9/2018Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
4/2016Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
9/2015Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne L Peters Research Topics

Disease

30Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 10/2013
22Hypoglycemia (Reactive Hypoglycemia)
03/2022 - 01/2013
18Type 2 Diabetes Mellitus (MODY)
10/2022 - 01/2007
12Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2021 - 06/2014
7Body Weight (Weight, Body)
12/2021 - 12/2009
6Hyperglycemia
03/2022 - 04/2015
5Ketosis
01/2021 - 04/2015
5Weight Loss (Weight Reduction)
12/2019 - 03/2012
3Prediabetic State (Prediabetes)
10/2022 - 11/2009
3Weight Gain
10/2018 - 12/2009
2Hypertension (High Blood Pressure)
12/2022 - 12/2019
2Overweight
12/2022 - 01/2022
2Obesity
12/2022 - 01/2014
2Infections
09/2018 - 04/2016
2Latent Autoimmune Diabetes in Adults
01/2018 - 01/2018
2Acidosis
04/2016 - 09/2015
2Cardiovascular Diseases (Cardiovascular Disease)
04/2015 - 12/2005
1Nephrolithiasis
01/2022
1Hypercalcemia (Milk Alkali Syndrome)
01/2022
1Hypercalciuria
01/2022
1Chronic Renal Insufficiency
12/2021
1COVID-19
06/2020
1Hyperplasia
12/2019
1Cushing Syndrome
12/2019
1Fatigue
12/2019
1Pre-Eclampsia (Preeclampsia)
01/2019
1Diarrhea
09/2018
1Coma (Comas)
04/2016
1Vomiting
09/2015
1Nausea
09/2015
1Insulinoma
08/2014
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2014
1Diabetes Mellitus
06/2013
1Pancreatitis
10/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2012
1Edema (Dropsy)
12/2009
1Glucose Intolerance
11/2009

Drug/Important Bio-Agent (IBA)

28Insulin (Novolin)FDA Link
12/2021 - 12/2009
26Glucose (Dextrose)FDA LinkGeneric
03/2022 - 11/2009
7Blood Glucose (Blood Sugar)IBA
01/2022 - 12/2009
7(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
12/2021 - 09/2018
6Sodium-Glucose Transport ProteinsIBA
01/2021 - 09/2015
4Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 09/2015
3KetonesIBA
01/2021 - 09/2015
3C-PeptideIBA
12/2016 - 03/2015
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2016 - 01/2013
2LipidsIBA
12/2022 - 12/2009
2Cholecalciferol (Vitamin D3)FDA Link
10/2022 - 01/2022
2Vitamin DFDA LinkGeneric
10/2022 - 01/2022
2SodiumIBA
12/2021 - 11/2019
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 11/2009
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2019 - 04/2016
2Sodium-Glucose Transporter 1IBA
09/2018 - 09/2018
2dulaglutideIBA
01/2018 - 01/2018
2CanagliflozinIBA
02/2017 - 04/2016
2SolutionsIBA
04/2015 - 01/2014
2Exenatide (Byetta)FDA Link
10/2012 - 01/2012
1HDL-triglycerideIBA
12/2022
1SilverIBA
06/2020
1glimepiride (Amarel)FDA LinkGeneric
01/2020
1dapagliflozinIBA
01/2020
1saxagliptinFDA Link
01/2020
1Mifepristone (RU 486)FDA Link
12/2019
1Glucagon (Glukagon)FDA Link
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1Insulin Aspart (NovoLog)FDA Link
10/2018
1CarbohydratesIBA
04/2018
1AntibodiesIBA
01/2018
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2018
1Hemoglobins (Hemoglobin)IBA
02/2017
14-nitro-3-dimethylaminopropiophenoneIBA
01/2016
1Glucagon-Like Peptide 1 (GLP 1)IBA
08/2014
1Insulin Lispro (Humalog)FDA Link
04/2014
1Insulin Glargine (Lantus)FDA Link
04/2014
1InsulinsIBA
01/2013
1ThiazolidinedionesIBA
12/2009
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2007
1LDL CholesterolIBA
12/2005
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2005

Therapy/Procedure

16Therapeutics
12/2021 - 01/2012
15Glycemic Control
11/2021 - 03/2012
2Islets of Langerhans Transplantation
12/2021 - 11/2021
2Injections
01/2021 - 10/2018
2Transition to Adult Care
03/2017 - 02/2017
1Investigational Therapies (Experimental Therapy)
03/2022
1Off-Label Use
01/2021
1Adrenalectomy
12/2019
1Occupational Therapy (Therapy, Occupational)
01/2018
1Activities of Daily Living (ADL)
12/2016
1Caloric Restriction
06/2013